AJG vs MFC

AJG's deterministic health score is weak, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score to confirm safety from distress. Despite strong revenue growth of 20% YoY, earnings are sharply declining (-25.2% YoY, -54% EPS), and the stock trades at a steep valuation (P/E 40.0, Forward P/E 19.06) well above sector averages. Insider selling is aggressive ($17.16M in net sales), and recent earnings misses have become frequent, with 3 out of the last 4 quarters missing estimates. While the balance sheet shows moderate leverage (Debt/Equity 0.59), weak profitability trends, deteriorating earnings momentum, and bearish technicals point to significant near-term risks.

MFC presents a complex profile with a stable Piotroski F-Score of 4/9 and no Altman Z-Score available for distress analysis. While the stock shows strong long-term price appreciation and a highly attractive PEG ratio (0.78), it is currently trading at a premium to both its Graham Number ($32.43) and Intrinsic Value ($15.75). The severe YoY revenue decline (-34.90%) is a significant concern, though it is offset by a massive Q/Q recovery (+103.98%) and a sustainable dividend profile.